DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
We also report that 13% of patients with type 1 diabetes in our registry use adjuvant glucose-lowering therapy in addition to insulin, significantly higher than the 5.4% reported from the T1D Exchange Registry in the US [18]
This may include adjusting fasting instructions, changing the timing of the appointment, or coordinating with the patients primary care provider or prescribing doctor to create a safe, personalized plan
Visit www.vitalityhealthsfl.com to learn more about the practice and the services we offer at Vitality Health SFL in Naples, Fort Myers, Bonita Beach, Miami, and Orlando, Florida